Contact Information: Contact: Dino Luzzi CEO Medivisor, Inc. 326 Walt Whitman Road Huntington Station, N.Y. 11746 Tel: 631.549.7100 http://www.medivisor.com
Medivisor Inc. Announces Update on LIPIDEME(TM)
| Source: Medivisor Inc.
HUNTINGTON STATION, NY--(Marketwire - September 16, 2008) - Medivisor, Inc. (PINKSHEETS : MVSR )
announced today that it intends to increase awareness for LIPIDEME™ in
Italy. LIPIDEME™ is a synergistic blend of ingredients designed to lower
cholesterol four ways. Since signing the initial revenue sharing agreement
with PanGenex Corporation, Medivisor has gathered initial interest for the
product and expects to begin shipping samples later in the month.
"With an abundance of people worldwide currently take cholesterol lowering
medication, and LIPIDEME™ addressing the need of those consumers, we
feel the market potential for this product is enormous," said Dino Luzzi,
CEO of Medivisor, Inc. "We have garnered strong LIPIDEME™ interest from
Italy, and once received from Pangenex, will be sending samples to a major
Italian distributor," furthered Mr. Luzzi.
Under its recently announced revenue sharing agreement with PanGenex
Corporation, Medivisor is responsible for generating sales growth for
LIPIDEME™ through both US and international distribution channels. The
American Heart Association estimates that nearly 140 million Americans have
either borderline-high or high cholesterol, as determined by a blood test
called a lipid panel. In 2003, approximately 22 million people took a
medication to try to lower their cholesterol. LIPIDEME™ is positioned
as an all-natural product to address high cholesterol from a dietary and
genetic standpoint.
About Medivisor Inc.:
Medivisor, Inc., a rapidly growing developer of next-generation focus
driven marketing tools. The company is dedicated to providing technologies
that offer innovative and competitive advantages to the bioscience and
pharmaceutical markets and beyond. From pre-product development through
product launch and commercialization, Medivisor offers worldwide experience
in delivering effective and successful integrated marketing and creative
communications campaigns for the mutual benefit of its clients.
http://www.medivisor.com
About PanGenex Corporation:
PanGenex is a publicly traded corporation and pursues business
opportunities in the $70 billion nutraceutical and dietary supplement
industry. With a focus on the cardiovascular health segment, PanGenex
develops and markets sector leading, patented or patent pending, condition
specific nutraceuticals and topical over-the-counter (OTC) drugs and
personal care products. Each product is scientifically formulated to
address specific health conditions. Many of our products contain the purest
grade of nutraceutical components available anywhere without a
prescription. PanGenex markets products through healthcare practitioners,
retail establishments and the internet on websites such as
www.PanGenex.com, www.Calgenex.com and www.HeartHealthyWorld.com.
Safe Harbor
This press release contains forward-looking statements within the meaning
of the Private Securities Litigation Reform Act of 1995 (the "Act")
Additionally, words such as "seek," "intend," "believe," "plan,"
"estimate," "expect," "anticipate" and other similar expressions are
forward-looking statements within the meaning of the Act. Some or all of
the events or results anticipated by these forward-looking statements may
not occur. Factors that could cause or contribute to such differences
include the performance ability of the initial units in the field. Further
information on Medivisor risk factors is contained in its filings with the
Securities and Exchange Commission. Medivisor does not undertake any duty
nor does it intend to update the results of these forward-looking
statements.